Oxime K074 – in vitro and in silico reactivation of acetylcholinesterase inhibited by nerve agents and pesticides

References

• Acharya, J., et al., 2009. Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase. European journal of medicinal chemistry, 44 (3), 1335–1340.
   PubMed Web of Science ®Google Scholar
• Antonijevic, B., and Stojiljkovic, M.P., 2007. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clinical medicine and research, 5 (1), 71–82.
   PubMedGoogle Scholar
• Artursson, E., et al., 2013. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity. Biochemical pharmacology, 85 (9), 1389–1397.
   PubMed Web of Science ®Google Scholar
• Besler, B.H., Merz, K.M., and Kollman, P.A., 1990. Atomic charges derived from semiempirical methods. Journal of computational chemistry, 11 (4), 431–439.
   Web of Science ®Google Scholar
• Borman, S., 2004. RNA route to nanoparticles. Chemical and engineering news, 82 (16), 9–39.
   Web of Science ®Google Scholar
• da Cunha, E.E.F., et al., 2010. Molecular modeling of Mycobacterium tuberculosis DNA gyrase and its molecular docking study with gatifloxacin inhibitors. Journal of biomolecular structure and dynamics, 27 (5), 619–625.
   PubMed Web of Science ®Google Scholar
• da Cunha, E.F.F., Ramalho, T.C., and Reynolds, R.C., 2008. Binding mode analysis of 2,4-diamino-5-methyl-5-deaza-6-substituted pteridines with Mycobacterium tuberculosis and human dihydrofolate reductases. Journal of biomolecular structure and dynamics, 25 (4), 377–385.
   PubMed Web of Science ®Google Scholar
• da Silva Gonçalves, A., et al., 2014. Reactivation steps by 2-PAM of tabun-inhibited human acetylcholinesterase: reducing the computational cost in hybrid QM/MM methods. Journal of biomolecular structure and dynamics, 32 (2), 301–307.
   PubMed Web of Science ®Google Scholar
• dos Santos, A.A., et al., 2010. In vitro reactivating effects of standard and newly developed oximes on malaoxon-inhibited mouse brain acetylcholinesterase. Basic & clinical pharmacology and toxicology, 107 (3), 768–773.
   PubMed Web of Science ®Google Scholar
• Frisch, M.J., et al., 1998. Gaussian 98, revision A. 7. Pittsburgh PA: Gaussian Inc.
   Google Scholar
• Giacoppo, J.O.S., et al., 2015. Molecular modeling and in vitro reactivation study between the oxime BI-6 and acetylcholinesterase inhibited by different nerve agents. Journal of biomolecular structure and dynamics, 33 (9), 2048–2058.
   PubMed Web of Science ®Google Scholar
• Gorecki, L., et al., 2016. A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication. Toxicology research, 5 (4), 1012–2859.
   Web of Science ®Google Scholar
• Guimarães, A.P., et al., 2011. Docking studies and effects of syn-anti isomery of oximes derived from pyridine imidazol bicycled systems as potential human acetylcholinesterase reactivators. Journal of applied biomedicine, 9 (3), 163–171.
   Web of Science ®Google Scholar
• Gupta, B., et al., 2014. In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes. Archives of toxicology, 88 (2), 381–390.
   PubMed Web of Science ®Google Scholar
• Gustin, D.J., et al., 1999. Heavy atom isotope effects reveal a highly polarized transition state for chorismate mutase. Journal of the American chemical society, 121 (8), 1756–1757.
   Web of Science ®Google Scholar
• Hehre, W.J., Deppmeier, B.J., and Klunzinger, P.E., 1999. PC Spartan pro, Irvine: Wave function Inc.
   Google Scholar
• Heyden, A., Lin, H., and Truhlar, D.G., 2007. Adaptive partitioning in combined quantum mechanical and molecular mechanical calculations of potential energy functions for multiscale simulations. The journal of physical chemistry. B, 111 (9), 2231–2241.
   PubMed Web of Science ®Google Scholar
• Jun, D., et al., 2008. TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate. Journal of chromatographic science, 46 (4), 316–319.
   PubMed Web of Science ®Google Scholar
• Jun, D., et al., 2010. High-performance liquid chromatography analysis of by-products and intermediates arising during the synthesis of the acetylcholinesterase reactivator HI-6. Journal of chromatographic science, 48 (8), 694–696.
   PubMed Web of Science ®Google Scholar
• Karasova, J.Z., et al., 2011. Partition of bispyridinium oximes (trimedoxime and K074) administered in therapeutic doses into different parts of the rat brain. Journal of pharmaceutical and biomedical analysis, 54 (5), 1082–1087.
   PubMed Web of Science ®Google Scholar
• Kassa, J., et al., 2008. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Mini reviews in medicinal chemistry, 8 (11), 1134–1143.
   PubMed Web of Science ®Google Scholar
• Kuca, K., et al., 2005a. Effective bisquaternary reactivators of tabun-inhibited AChE. Journal of applied toxicology, 25 (6), 491–495.
   PubMed Web of Science ®Google Scholar
• Kuca, K., and Cabal, J., 2005b. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin nerve agent. Toxicology mechanisms and methods, 15 (4), 247–252.
   PubMed Web of Science ®Google Scholar
• Kuca, K., Cabal, J., and Kassa, J., 2005c. In vitro reactivation of sarin-inhibited brain acetylcholinesterase from different species by various oximes. Journal of enzyme inhibition and medicinal chemistry, 20 (3), 227–232.
   PubMed Web of Science ®Google Scholar
• Kuca, K., and Patocka, J., 2004. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. Journal of enzyme inhibition and medicinal chemistry, 19 (1), 39–43.
   PubMed Web of Science ®Google Scholar
• Kuca, K., et al., 2010. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase. Journal of enzyme inhibition and medicinal chemistry, 25 (4), 509–512.
   PubMed Web of Science ®Google Scholar
• Kuca, K., Juna, D., and Musilek, K., 2006. Structural requirements of acetylcholinesterase reactivators. Mini reviews in medicinal chemistry, 6 (3), 269–277.
   PubMed Web of Science ®Google Scholar
• Li, R., et al., 2012. An isofenphos-methyl hydrolase (Imh) capable of hydrolyzing the P-O-Z moiety of organophosphorus pesticides containing an aryl or heterocyclic group. Applied microbiology and biotechnology, 94 (6), 1553–1564.
   PubMed Web of Science ®Google Scholar
• Lonsdale, R., Ranaghan, K.E., and Mulholland, A.J., 2010. Computational enzymology. Chemical communications, 46 (14), 2354–2372.
   PubMed Web of Science ®Google Scholar
• Lorke, D.E., et al., 2008a. Entry of oximes into the brain: a review. Current medicinal chemistry, 15 (8), 743–753.
   PubMed Web of Science ®Google Scholar
• Lorke, D.E., et al., 2008b. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate. Journal of applied toxicology, 28 (4), 422–429.
   PubMed Web of Science ®Google Scholar
• Lundy, P.M., et al., 2011. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning. Toxicology, 285 (3), 90–96.
   PubMed Web of Science ®Google Scholar
• Matos, K.S., et al., 2011. Journal of Brazilian chemical society, 22 (10), 1999–2004.
   Web of Science ®Google Scholar
• Matos, K.S., et al., 2014. Computational evidence for the reactivation process of human acetylcholinesterase inhibited by carbamates. Combinatorial chemistry & high throughput screening, 17 (6), 554–564.
   PubMed Web of Science ®Google Scholar
• McHardy, S.F., et al., 2014. Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. Bioorganic & medicinal chemistry letters, 24 (7), 1711–1714.
   PubMed Web of Science ®Google Scholar
• Minton, N.A., and Murray, V.S., 1988. A review of organophosphate poisoning. Medical toxicology and adverse drug experience, 3 (5), 350–375.
   PubMedGoogle Scholar
• Misik, J., et al., 2015. Acute toxicity of some nerve agents and pesticides in rats. Drug and chemical toxicology, 38 (1), 32–36.
   PubMed Web of Science ®Google Scholar
• Musílek, K., et al., 2006. Chemical papers, 60 (1), 48–51.
   Web of Science ®Google Scholar
• Muśilek, K., et al., 2007a. Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). Journal of medicinal chemistry, 50 (22), 5514–5518.
   PubMed Web of Science ®Google Scholar
• Muśilek, K., et al., 2007b. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker—synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorganic & medicinal chemistry letters, 17 (11), 3172–3176.
   PubMed Web of Science ®Google Scholar
• Musilek, K., et al., 2011. Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. Medicinal research reviews, 31 (4), 548–575.
   PubMed Web of Science ®Google Scholar
• Nepovimova, E., et al., 2016. A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication. Toxicology research, 5 (4), 1012–1016.
   Web of Science ®Google Scholar
• Petroianu, G.A., et al., 2007. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon. Journal of applied toxicology, 27 (2), 168–175.
   PubMed Web of Science ®Google Scholar
• Ramalho, T.C., da Cunha, E.F.F., and de Alencastro, R.B., 2004. Solvent effects on 13 C and 15 N shielding tensors of nitroimidazoles in the condensed phase: a sequential molecular dynamics/quantum mechanics study. Journal of physics: condensed matter, 16 (34), 6159–6170.
   Web of Science ®Google Scholar
• Ramalho, T.C., et al., 2009. Construction and assessment of reaction models of class I EPSP synthase: molecular docking and density functional theoretical calculations. Journal of biomolecular structure & dynamics, 27 (2), 195–207.
   PubMed Web of Science ®Google Scholar
• Rosman, Y., et al., 2014. Lessons learned from the Syrian sarin attack: evaluation of a clinical syndrome through social media. Annals of internal medicine, 160 (9), 644–648.
   PubMed Web of Science ®Google Scholar
• Rutkowska-Zbik, D., and Witko, M., 2006. Following nature—theoretical studies on factors modulating catalytic activity of porphyrins. Journal of molecular catalysis A: chemical, 258 (1-2), 376–380.
   Google Scholar
• Singh, U.C., and Kollman, P.A., 1984. An approach to computing electrostatic charges for molecules. Journal of computational chemistry, 5 (2), 129–145.
   Web of Science ®Google Scholar
• Tekes, K., et al., 2006. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator. Journal of chromatography A, 1122 (1/2), 84–87.
   PubMed Web of Science ®Google Scholar
• Thomsen, R., and Christensen, M.H., 2006. MolDock: a new technique for high-accuracy molecular docking. Journal of medicinal chemistry, 49 (11), 3315–3321.
   PubMed Web of Science ®Google Scholar
• Wiesner, J., et al., 2007. Acetylcholinesterases—the structural similarities and differences. Journal of enzyme inhibition and medicinal chemistry, 22 (4), 417–424.
   PubMed Web of Science ®Google Scholar
• Worek, F., et al., 2010. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach. Toxicology and applied pharmacology, 249 (3), 231–237.
   PubMed Web of Science ®Google Scholar
• Worek, F., et al., 2012. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase. Archives of toxicology, 86 (9), 1379–1386.
   PubMed Web of Science ®Google Scholar